Key result
The provided text is a journal masthead and does not contain clinical study data.
Why the study?
Does low-molecular-weight heparin improve the prevention and treatment of VTE and pregnancy complications in pregnant women compared to unfractionated heparin?
Population
Pregnant women, particularly those with inherited or acquired thrombophilias at risk of venous…
Comparison
Low-molecular-weight heparin (LMWH) vs Unfractionated heparin (UFH) or aspirin
Design
Review
Authors
Loading...
Hypothesis-generating for LMWH in pregnancy VTE; prospective RCTs needed before practice change.
Does low-molecular-weight heparin improve the prevention and treatment of VTE and pregnancy complications in pregnant women compared to unfractionated heparin?
LMWH is an effective and safer alternative to UFH for the prevention and treatment of VTE and potentially recurrent fetal loss during pregnancy.
Kher et al. (2007) studied this question. The provided text is a journal masthead and does not contain clinical study data.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: